Comments on: Dunkley: Marijuana Decriminalization Discussion

By: Marijuana Decriminalization Consultation Paper | Bernews.com

Marijuana Decriminalization Consultation Paper | Bernews.com — Tue, 12 Nov 2013 14:02:04 +0000

[...] the second time in recent weeks the concept has been brought up, with Public Safety Minister Dunkley recently saying: “I think it is necessary to acknowledge the public debate in Bermuda and overseas that [...]

By: sage

sage — Fri, 25 Oct 2013 16:32:29 +0000

That’s all I eat,no need for pressure,sugar and cholesterol meds for me.

By: sage

sage — Fri, 25 Oct 2013 16:29:09 +0000

How can it be illegal to sell something you can freely give away, even when under the influence?

By: sage

sage — Fri, 25 Oct 2013 16:09:47 +0000

Yup,always followers never trendsetters.This is our only opportunity to create an industry which capitalizes on something we can produce locally by bermudians for bermudians,the true definition of buy bermuda,a renewable resource, a sustainable development with potential for medical,tourism,job creation(for locals),and allows law enforcement to redirect resources towards real crime,and ends incarceration, discrimination,marginalization,denying opportunities to many otherwise law abiding citizens.An industry the small man can get into,with regulation preventing big business from taking over,trickle up effect,rather than waiting on crumbs to fall off the table.

By: Sara

Sara — Fri, 25 Oct 2013 14:22:23 +0000

Just like with tourism, we will fall behind and miss a good opportunity to create jobs and raise revenue.

By: Sara

Sara — Fri, 25 Oct 2013 14:19:30 +0000

Now that many U.S. states have legalized for medical use with some legalizing for recreational use, many countries are moving full speed ahead with legalization since the U.S. can no longer bully them. Jamaica and Mexico City are jumping on board. Bermuda is WAY behind.

By: Come Correct

Come Correct — Fri, 25 Oct 2013 13:31:45 +0000

Weed has the complete opposite effect of everything else you mentioned, so saying it leads to those things makes no sense.

By: Come Correct

Come Correct — Fri, 25 Oct 2013 13:20:24 +0000

That’s not even what a narcissist is you numpty. You took what I said and tried to add a label. Failed attempt.

By: Come Correct

Come Correct — Fri, 25 Oct 2013 13:12:10 +0000

Oblivious and ignorant would be not realizing the black market does nothing but fund these gangs and the violence you speak of. So the government should legalize and tax it to take the cash away from the gangs and into the government as a new revenue steam that can be used to subsidize more important things. That would be better for all or do you have a better plan to stop the gangs? Silly girl, repeating things about “potheads” doesn’t make it true, just shows how uninformed you are and your need to attack the messenger.

By: Tommy Chong

Tommy Chong — Fri, 25 Oct 2013 12:50:02 +0000

I won’t claim that I know everything but it’s obvious I know more than you since you’re ignorant of the relation between gang shootings & the legality of drugs. I’m guessing you believe Al Capone shot all his victims because he wanted to see how well his tommy gun worked no because he wanted to wipe the competition of the lucrative black market trade of alcohol during its prohibition.

I bet you also believe Ronald Regan when he said, “I now have absolute proof that smoking even one marijuana cigarette is equal in brain damage to being on Bikini Island during an H-Bomb blast.”

The herb smokers better be careful because they might bring on the apocalypse by lighting a joint. LMAWO!!!!!!

NEEEEEEEXXXT!!!!!

By: jt

jt — Fri, 25 Oct 2013 11:38:17 +0000

Bananas, paw paws and chub. Hope you like them Alvin.

By: think outside the box

think outside the box — Fri, 25 Oct 2013 11:29:27 +0000

punish the dealer and importer??then the user is now out of luck then?

By: think outside the box

think outside the box — Fri, 25 Oct 2013 11:27:31 +0000

agreed

By: jaos

jaos — Fri, 25 Oct 2013 11:25:31 +0000

Nicely done. Trust that if one of my family or friends was suffering, I would recommend it. It’s proven so let’s open minds and take a lying leap forward into 2013!

By: Keepin' it Real...4Real!

Keepin' it Real...4Real! — Fri, 25 Oct 2013 08:48:10 +0000

HEY NEXT!…EDUCATE YOURSELF , THEN COME TO THE TABLE WITH VIABLE REASONS FOR YOUR MENTAL INCAPACITIES…

By: Keepin' it Real...4Real!

Keepin' it Real...4Real! — Fri, 25 Oct 2013 08:44:56 +0000

NEXT MUST BE DRUNK COZ IT JUST WONT SHUT UP…GEESH!

By: Keepin' it Real...4Real!

Keepin' it Real...4Real! — Fri, 25 Oct 2013 08:43:24 +0000

NEXT!!!…UR STILL AN UNINTELLIGENT A**!!!…SHUT UP!

By: Keepin' it Real...4Real!

Keepin' it Real...4Real! — Fri, 25 Oct 2013 08:41:44 +0000

NEXT!!!….UR JUS AN UNINTELLIGENT A**…SHUT UP!

By: Robert

Robert — Fri, 25 Oct 2013 01:43:06 +0000

Just give me the light and pass the draw !

By: Robert

Robert — Fri, 25 Oct 2013 01:41:25 +0000

Legalization would be the best way to do it. Decriminalization means its still an offense to import it, legalised and controlled cultivate would bring revenue to govt .

By: Robert

Robert — Fri, 25 Oct 2013 01:31:36 +0000

I beg to differ, weed doesn’t mean you will eventually move on to more addictive and harmful drugs. I know many people who smoke weed and have no desire to partake in any other form of narcotic.

By: Concerned Citizen

Concerned Citizen — Fri, 25 Oct 2013 01:15:35 +0000

Yup, Lebron is clueless. No need to read his post anymore.

By: Lebron

Lebron — Fri, 25 Oct 2013 00:16:04 +0000

No, one thing leads to another. Weed, to speed, to pills, to nose, to meth to horse.

No thank you.

By: Next

Next — Fri, 25 Oct 2013 00:07:02 +0000

You’re so dumb and transparent. He is sensitive complaining about a term that people who smoke weed themselves use. Get over it.

I don’t drink. Your argument is poor. It is not legal all over in those countries. Try again. I didn’t put down anyone. I was attacked for my opinion as well so YOU don’t be so one sided and stupid with your convenient eyes.

By: michael brangman

michael brangman — Fri, 25 Oct 2013 00:05:45 +0000

Oh yeah. Mark Bean made me proud. A politician who told the truth. Meanwhile minister dunkley tap dances around the issue.

Bullet

By: YADON

YADON — Thu, 24 Oct 2013 23:29:10 +0000

Every One Copy and paste this everywhere we can. It’s time to get the TRUTH out !!!

By: haha

haha — Thu, 24 Oct 2013 23:15:07 +0000

He’s not sensitive, he’s replying to you. If you weren’t so one sided and selfish/biased you’d see enough common sense to see what he had wrote. Just because you don’t indulge in smoking weed doesn’t mean it’s not important to the greater community.

As far as um concerned it fits under the “drugs” part surrounding out community, even though I don’t see it as a drug, which also includes the breezers you drink after 5pm on Friday, which are worse for you. To each his own, but don’t put down people because they enjoy something you don’t, and to say it’s not an important matter, they you must be the one thats killing brain cells, why would the UK, United States and other various countries legalize/decriminalize marijuana?! Yeah I thought so…STOP being so SELFISH and MORONIC!

By: Alvin Williams

Alvin Williams — Thu, 24 Oct 2013 23:13:46 +0000

Well one good thing we may see come out of this; is the end of raids on the cruise ships just so we can subject those who smoke weed to massive court fines. It just like the days Bermudians used to set fires on hills
hoping passing ship would be wreak on our reefs; than we would commence to
loot them. Once a pirate always a pirate whether that means fleecing the poor tourist on the cruise ships who happens to smoke a little weed on his
holiday or providing a haven for international companies who don’t want to pay the full measure of tax to their national governments.

By: Next

Next — Thu, 24 Oct 2013 23:10:56 +0000

I didn’t call you a pothead. Looks like we have another narcissist on our hands. Contrary to you and “Come Correct” beliefs, the world doesn’t revolve around you two. I spoke in general, you decided to jump up and reply. As usual since you two sit on BERNEWS all day and night arguing with everyone. A hit dog will holler?

Anyway to the rest of your comment, no. There is no link. At all.

It’s only important to people who smoke weed. It is of no benefit or importance to Bermuda as a whole. Especially not in the midst of us having one of the highest murder rates in the world.

By: Next

Next — Thu, 24 Oct 2013 23:05:29 +0000

Ah another one who can’t read between the lines, that was to say gang violence and violence in general is a more pressing issue. You know that thing that’s partly the reason the tourists don’t come here anymore? Uh but I digress. Potheads are too busy worrying about themselves and the “pressing” issue of legalizing their pot. You’re right I don’t care so why not give me that right the same right to freedom to do what you want as you so claim? I’m not thinking selfishly when I’m more concerned about the good of all of Bermuda and stamping out guns and violence, you all on the other-hand are more concerned about yourselves and being free to smoke weed. You are free to do it. You can’t see that? Of course not because you’re self centered, most likely a narcissist. Feel free to be oblivious and ignorant.

By: Mike Hind

Mike Hind — Thu, 24 Oct 2013 22:29:14 +0000

Consent.
If there is a way to guarantee that the sex is consensual, I have no problem with figuring out a way to do this…

By: Wino

Wino — Thu, 24 Oct 2013 22:12:05 +0000

Why stop there? What about prostitution? God made man and woman. The law punishes one for marketing a natural pleasure.

By: Mike Hind

Mike Hind — Thu, 24 Oct 2013 22:06:03 +0000

I’ve been clean and sober for over 23 years, so… “pothead”? I don’t think so.

You talk about “Let’s start with 18 year-olds being hammered in the head…”
Do you not see that there could possibly be a link between the criminalization of our youth for pot and… you know… our youth acting like criminals?

There ARE more important matters… but that doesn’t mean that this one should be put aside.

Just because you don’t think this is important doesn’t mean that it isn’t important to others.

By: Come Correct

Come Correct — Thu, 24 Oct 2013 21:58:11 +0000

Ah, we should focus on the pressing matter of a teenager who went to the area to participate in anti-social activity organized on social media….bad example killa. The pressing matter here, as stated in the article is that our youth are bing denied access to further education because they choose to use a plant. There isn’t one person on this planet that can stop me from going to the grocery store, buy a bottle of bleach and drink it,so why is that not illegal? No one on this planet can stop me from drinking enough WATER to flood my vital organs. So why exactly is there a law against marijuana? People are being made criminals out of something that is not criminal, that is the ongoing pressing issue. You don’t care because you don’t use and thus will never be demonized which is selfish at the very least. If you hadn’t notice us “pot heads” comment on other topics too so clearly we aren’t so self-absorbed to think everything is about us. Feel free to carry on, FEED ME!….Oh…nothing about cancer….

By: sage

sage — Thu, 24 Oct 2013 21:49:45 +0000

Well that’s quite a bit of research for Minister Dunkley to ignore,studies looking for positive results have been stymied for years due,among other reasons,to the classification of herb as schedule 1 alongside heroin and above cocaine as having a high potential for abuse and no medical benefits,which is so ridiculous it would be laughable if the consequences weren’t so disastrous.This needs to be changed immediately to reflect reality.Do not “just say no” to the facts and discontinue your “zero tolerance”on compassion all you ganjaphobes try it you might like it don’t wait util you are sick and need it.Nice work Yadon.

By: Next

Next — Thu, 24 Oct 2013 21:33:41 +0000

Newsflash: Everything isn’t about you potheads! You haven’t obliterated anything but your brain cells. No one cares about your plight to smoke weed. Nowhere did I say he should focus on ONE thing. I said he should focus on more important thing(s), emphasis on the S at the end. WEED is not on the list of top concerns for Bermuda. Let’s start with 18 year olds being hammered in the head in broad daylight.

ONGOING AND PRESSING MATTER? Bwahahahahahaaaaaaa! Let me guess your next comment, it cures cancer. HAAAAAAAAAAAA. Thank you for proving my point.

By: Next

Next — Thu, 24 Oct 2013 21:27:35 +0000

Nice copy and paste job.

You still sensitive though.

By: Come Correct

Come Correct — Thu, 24 Oct 2013 21:14:27 +0000

So what is? Should each minister concentrate their efforts on one thing at a time? How much would get done then? I find it hilarious how every time there is an article on this topic “pot heads” completely obliterate the arguments of so called normal thinking people and yet you have the audacity to talk about brain cells. Just because this topic doesn’t concern you doesn’t mean it isn’t an ongoing and pressing matter. NEWSFLASH: Everything isn’t about YOU.

By: jt

jt — Thu, 24 Oct 2013 20:58:40 +0000

Jeesh – just relax everyone – breath deeply..hold…exhale slowly……..there, better?

By: YADON

YADON — Thu, 24 Oct 2013 20:46:40 +0000

Wow, Next: You really must have never heard of Google before. There is no other explanation for you flat out ignorance on his topic and the misinformation you posted. Science has detailed how we have co-evolved with this plant for 100K years. We have developed both neural and somatic sites specific for cannabis. Many pain meds work because they bind to these sites. British doctors working in India 150 years ago documented nearly 1,500 different medical conditions cannabis was most-effective in curing and or managing. Even idiots know that the psycho-tropic effects among long-term users are minimal. If you have real information to post, that’s one thing. But posting fantasy slanted for the benefit of Corporations and to the detriment of the well being of us all is totally irresponsible and I’m calling you out on it. Shame on you liars!

By: Bermale

Bermale — Thu, 24 Oct 2013 20:40:12 +0000

Guess the poster is reaffirming the belief that the PLP are much more effective at being an Opposition Party as opposed to being an effective Governing Party.

By: Next

Next — Thu, 24 Oct 2013 20:32:03 +0000

Why are you so sensitive? Potheads call themselves potheads so get over it. And that’s your opinion not fact. I’ve seen otherwise. “scare mongorers”? LOL. You surely aren’t helping the belief that it kills brain cells.

By: Next

Next — Thu, 24 Oct 2013 20:27:49 +0000

LMAO! Yeah okay if you say so Mr. Chong, because as we all know, you know everything.

By: YADON

YADON — Thu, 24 Oct 2013 20:26:53 +0000

The US Federal Government patented cannabinoids as antioxidants and neuroprotectants in US Patent #6630507; it mentions Alzheimer’s disease, Parkinson’s disease, stroke, neurological trauma, HIV dementia, and autoimmune disorders as conditions for which cannabinoids may be indicated, and though more research is needed to determine the proper doses, routes of administration, and profiles of active compounds (e.g. terpenes [like pinene, limonene, and myrcene], flavonoids [like apigenin], and cannabinoids [like CBD, THCV, CBN, and THC]), CANNABlS may be indicated as a way to treat, prevent, and/or cure numerous other conditions, including cancers, organ damage and nausea induced by chemotherapy and radiation, chemotherapy resistance, diabetes and its complications, osteoporosis, exostosis, atherosclerosis, sepsis, reperfusion injury, obesity, microbial infections (including MRSA, brain-eating amoebae, and herpes), anxiety disorders (e.g. GAD, PTSD, and OCD), stroke damage, bipolar disorder, schizophrenia, Tourette’s syndrome, epilepsy, autism, depression, insomnia, spasticity, dystonia, dyskinesia, acne, psoriasis, allergic contact dermatitis, pruritis, asthma, fibromyalgia, lupus, migraine, vascular dementia, chronic kidney disease, liver diseases, chronic pancreatitis, Crohn’s disease, colitis, IBS, Huntington’s disease, prion diseases, arthritis, MS, ALS, pain, GVHD, organ transplant rejection, sleep apnea, incontinence, and metabolic syndrome. Smoking CANNABlS was found by UCLA researchers to not be linked with either lung cancer or COPD, but bronchitis was mentioned; if CANNABlS were re-legalized, non-smoking methods for using it could be promoted (e.g. vapor and oral). Strains of CANNABlS with low (or no) psychoactivity exist (e.g. CBD-rich) but Drug Prohibition hinders access to them. CANNABlS has astounding medical potential beyond its psychoactivity. Even the worst effects of CANNABlS are not as dangerous as the laws that ban it. Harm reduction is the only honest and effective way to deal with drugs, as Drug Prohibition has amplified or created any problems associated with drugs so special interests could exploit the issue for money and power.

Sources:

ADSI. 2013. Federal Government Reports Marijuana Effective in Combatting Certain Cancers Reports ADSI. NBC News. GlobeNewswire.

American Thoracic Society. 2006. Study Finds No Link Between Marijuana Use and Lung Cancer. Science Daily. Web. 2013.

Anderson, D., and D. Rees. 2011. M(edical M(arijuana Laws, Traffic Fatalities, and Alcohol Consumption. IZA Discussion Paper No. 6112.

Anderson, D., Rees, D., and J. Sabia. 2012. High on Life? M(edical M(arijuana Laws and Suicide. IZA Discussion Paper No. 6280.

Appendino, G. et al. 2008. Antibacterial cannabinoids from CANNABlS sativa: a structure-activity study. Journal of Natural Products. 71(8):1427-30.

Arnold, J. et al. 2012. CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells.Pharmacological Reports. 64(3):751-7.

Ashton, C. et al. 2005. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. Journal of Psychopharmacology. 19(3):293-300.

Ashton, C., and P. Moore. 2011. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 124(4):250-61.

Bab, I., Zimmer, A., and E. Melamed. 2009. Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Annals of Medicine. 41(8):560-7.

Bátkai, S. et al. 2012. Delta (8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. British Journal of Pharmacology.165(8):2450-61.

Biegon, A. 2004. Cannabinoids as neuroprotective agents in traumatic brain injury. Current Pharmaceutical Design. 10(18):2177-83.

Blázquez, C. et al. 2006. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB Journal. 20(14):2633-5.

Blázquez, C. et al. 2008. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Research. 68(6):1945-52.

Bolognini, D. et al. 2010. The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. British Journal of Pharmacology. 160(3):677–687.

Booz, G. 2011. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radical Biology and Medicine. 51(5):1054-61.

Brown, I. et al. 2013. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. Progress in Lipid Research. 52(1):80-109.

Cabral, G., and L. Griffin-Thomas. 2008. Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocrine, Metabolic & Immune Disorders Drug Targets. 8(3):159-72.

Caffarel, M. et al. 2008. JunD is involved in the antiproliferative effect of Delta(9)-tetrahydrocannabinol on human breast cancer cells. Oncogene. 27(37):5033-44.

Caffarel, M. et al. 2010. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Molecular Cancer. 9:196.

Capasso, R. et al. 2011. Inhibitory effect of standardized CANNABlS sativa extract and its ingredient cannabidiol on rat and human bladder contractility. Urology. 77(4):1006.e9-15.

Carley, D. et al. 2002. Functional role for cannabinoids in respiratory stability during sleep. Sleep. 25(4):391-8.

Carrol, C. et al. 2012. Δ(9) -tetrahydrocannabinol (Δ(9) -THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease. Neuropathology & Applied Neurobiology. 38(6):535-47.

Carter, G. et al. 2010. CANNABlS and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. The American Journal of Hospice and Palliative Care. 27(5):347-56.

Casanova, M. et al. 2003. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. The Journal of Clinical Investigation. 111(1):43-50.

Cassol-Jr, O. et al. 2010. Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Research. 1348:128-38.

Comelli, F. et al. 2009. Beneficial effects of a CANNABlS sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytotherapy Research. 23(12):1678–84.

Crippa, J. et al. 2011. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of Psychopharmacology. 25(1):121-30.

Davison, S., and J. Davison. 2011. Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? Journal of Pain and Symptom Management. 41(4):768-78.

de Lago, E. et al. 2012. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology. 62(7):2299-308.

Di Marzo, V. 2008. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 51(8):1356–67.

De Petrocellis, L. et al. 2013. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. British Journal of Pharmacology. 168(1):79-102.

Dirikoc, S. et al. 2007. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. The Journal of Neuroscience. 27(36):9537-44.

Domoslawski, A. 2011. Drug Policy in Portugal: The Benefits of Decriminalizing Drug Use. Global Drug Policy Program. Open Society Foundations. 47 pp. ISBN: 978-1-936133-51-2.

Donadelli, M. et al. 2011. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death and Disease. 2:e152.

El-Alfy, A. et al. 2010. Antidepressant-like effects of Delta9-tetrahydrocannabinol and other cannabinoids from CANNABlS sativa L. Pharmacology, Biochemistry, and Behavior. 95(4): 434-42.

El-Remessy, A. et al. 2006. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. The American Journal of Pathology. 168(1):235-44.

El-Remessy, A. et al. 2010. Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. Molecular Vision. 16:1487-95.

F(agherazzi, E. et al. 2012. Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology (Berl). 219(4):1133-40.

Fernández-Ruiz, J. et al. 2011. Prospects for cannabinoid therapies in basal ganglia disorders. British Journal of Pharmacology. 163(7):1365-78.

Fox, S. et al. 2002. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson’s disease. Movement Disorders. 17(6):1180-7.

Freimuth, N., Ramer, R., and B. Hinz. 2010. Antitumorigenic effects of cannabinoids beyond apoptosis. The Journal of Pharmacology and Experimental Therapeutics. 332(2):336-44.

García-Arencibia, M. et al. 2007. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Research. 1134(1):162-70.

García-Arencibia, M. et al. 2009. Cannabinoids and Parkinson’s disease. CNS and Neurological Disorders Drug Targets. 8(6):432-9.

Gardner, F. 2013. As Anecdotal Reports of Anti-Cancer Effects from CANNABlS ‘Oil’ Pile Up, Doctors Stress Need to Document Its Effects. Alternet. O’Shaughnessy’s.

Gauter, B., Rukwied, R., and C. Konrad. 2004. Cannabinoid agonists in the treatment of blepharospasm–a case report study. Neuro Endocrinol Lett. 25(1-2):45-8.

Gowran, A. et al. 2011. The multiplicity of action of cannabinoids: implications for treating neurodegeneration. CNS Neuroscience & Therapeutics. 17(6):637-44.

Guindon, J., and P. Beaulieu. 2009. The role of the endogenous cannabinoid system in peripheral analgesia. Current Molecular Pharmacology. 2(1):134-9.

Guindon, J., and A. Hohmann. 2011. The endocannabinoid system and cancer; therapeutic implication. British Journal of Pharmacology. 163(7):1447-63.

Gustafsson, K. et al. 2008. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. International Journal of Cancer. 123(5):1025-33.

Guzmán, M. 2003. Cannabinoids: potential anticancer agents. Nature Reviews. Cancer. 3(10):745-55.

Hasan, A. et al. 2010. Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report. Journal of Clinical Psychopharmacology. 30(2):190-2.

Hashibe, M. et al. 2005 Epidemiologic review of marijuana use and cancer risk. Alcohol. 35(3):265-75.

Hayakawa, K. et al. 2007. Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism. Journal of Neurochemistry. 102(5):1488-96.

Hill, A., Williams, C., Whalley, B., and G. Stephens. 2012. Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol. Ther.133(1):79-97.

Hillard, C. 2008. Role of cannabinoids and endocannabinoids in cerebral ischemia. Current Pharmaceutical Design. 14(23):2347-61.

Holland, M., Allen, J., and J. Arnold. 2008. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European Journal of Pharmacology. 591(1-3):128-31.

Horváth, B. et al. 2012. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radical Biology and Medicine. 52(8):1325-33.

Horváth, B. et al. 2012. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. The American Journal of Pathology. 180(2):432-42.

Howard, J. et al. 2005. CANNABlS use in sickle cell disease: a questionnaire study. British Journal of Haematology. 131(1):123-8.

Hsieh, G. et al. 2011. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. British Journal of Pharmacology. 162(2):428-40.

Huang, H. et al. 2012. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology. 56(1):248-58.

Ibrahim, M. et al. 2005. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proceedings of the National Academy of Sciences of the U S A. 102(8):3093-8.

Idris, A., S. Ralston. 2012. Role of cannabinoids in the regulation of bone remodeling. Frontiers in Endocrinology.3:136.

Igon’kina, S. et al. 2011. Analgesic effects of cannabinoids on central pain syndrome. Patol Fiziol Eksp Ter. (4):51-4.

Jabusch, H., Schneider, U., and E. Altenmüller. 2004. Delta9-tetrahydrocannabinol improves motor control in a patient with musician’s dystonia. Movement Disorders. 19(8):990-1.

Jeon, P. et al. 2011. Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction. Anatomy and Cell Biology. 44(2):135-42.

Johanek, L., and D. Simone. 2004. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury. Pain. 109(3):432-42.

Jones, N. et al. 2010. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 332(2):569-77.

Karl, T. et al. 2012. The therapeutic potential of the endocannabinoid system for Alzheimer’s disease. Expert Opinion on Therapeutic Targets. 16(4):407-20.

Karsak, M. et al. 2007. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 316(5830):1494-7.

Karst, M. et al. 2010. Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs. 70(18):2409-38.

Kimball, E. et al. 2006. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. American Journal of Physiology. Gastrointestinal and Liver Physiology. 291(2):G364-71.

Klein, T. 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews. Immunology. 5(5):400-11.

Kohli, D. et al. 2010. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood. 116(3):456-65.

Kozela, E. et al. 2011. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. British Journal of Pharmacology. 163(7):1507-19.

Kupczyk, P., Reich, A., and J. Szepietowski. 2009. Cannabinoid system in the skin – a possible target for future therapies in dermatology. Experimental Dermatology. 18(8):669-79.

Kwiatkoski, M. et al. 2012. Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury. Neurotoxicity Research. 21(3):271-80.

Lakhan, S. and M. Rowland. 2009. Whole plant CANNABlS extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurology. 9:59.

Lancz, G., Specter, S., and H. Brown. 1991. Suppressive effect of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro. Proceedings of the Society for Experimental Biology and Medicine. 196(4):401-4.

LEAP (Law Enforcement Against Prohibition)

Leelawat, S. et al. 2010. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Cancer Investigation. 28(4):357-63.

Lehman, C. et al. Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis. Critical Care. 2012. 16(2): R47.

Leussink, V. et al. 2012. Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Therapeutic Advances in Neurological Disorders. 5(5):255-66.

Leweke, F. et al. 2012. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry. 2:e94.

Li, C., Bowe, J., Jones, P., and S. Persaud. 2010. Expression and function of cannabinoid receptors in mouse islets. Islets. 2(5):293-302.

Li, C., Jones, P., and S. Persaud. 2010. Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cellular Physiology and Biochemistry. 26(2):187-96.

Ligresti, A. et al. 2006. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. The Journal of Pharmacology and Experimental Therapeutics. 318(3):1375-87.

Little, J. et al. 2011. Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson’s disease. Mini Reviews in Medicinal Chemistry. 11(7):582-90.

Liu, W. et al. 2008. Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach. Leukemia and Lymphoma. 49(9):1800-9.

Lynch, M., and F. Campbell. 2011. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. British Journal of Pharmacology. 72(5):735-44.

Marchalant, Y. et al. 2012. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 16;9:10.

Marcu, J. et al, 2010. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Molecular Cancer Therapeutics. 9(1):180-9.

Martín-Moreno, A. et al. 2011. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease. Molecular Pharmacology. 79(6):964-73.

Martín-Moreno, A. et al. 2012. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. Journal of Neuroinflammation. 9:8.

Massi, P. et al. 2004. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. The Journal of Pharmacology and Experimental Therapeutics. 308(3):838-45.

McKallip, R. et al. 2006. Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Molecular Pharmacology. 70(3):897-908.

McAllister, S. et al. 2011. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Research and Treatment. 129(1):37-47.

McPartland, J. and P. Pruitt. 1999. Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana. Alternative therapies in health and medicine. 5(4):57-62.

Mishima, K. et al. 2005. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke. 36(5):1077-82.

Miyato, H. et al. 2009. Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. The Journal of Surgical Research. 155(1):40-7.

MPP (Marijuana Policy Project)

Murikinati, S. et al. 2010. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB Journal. 24(3):788-98.

Naftali, T. et al. 2011. Treatment of Crohn’s disease with CANNABlS: an observational study. The Israel Medical Association Journal. 13(8):455-8.

Namazi, M. 2005. Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition. Journal of European Academy of Dermatology and Venereology. 19(3):319-22.

Nagarkatti, M. et al. 2010. Do cannabinoids have a therapeutic role in transplantation? Trends in Pharmacological Science. 31(8):345-50.

Nok, A. et al. 1994. The trypanocidal effects of CANNABlS sativa constituents in experimental animal trypanosomiasis. Veterinary and Human Toxicology. 36(6):522-4.

NORML (National Organization for the Reform of Marijuana Laws)

Oesch, S. et al. 2009. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Molecular Cancer Therapeutics. 8(7):1838-45.

Osei-Hyiaman, D. 2007. Endocannabinoid system in cancer cachexia. Current Opinion in Clinical Nutrition and Metabolic Care. 10(4):443-8.

Pacher, P., and R. Mechoulam. 2011. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Progress in Lipid Research. 50(2): 193–211.

Pacher, P., and S. Steffens. 2009. The emerging role of the endocannabinoid system in cardiovascular disease. Semin. Immunopathology. 31(1):63–77.

Pan, H. et al. 2009. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. The Journal of Pharmacology and Experimental Therapeutics. 328(3):708-14.

Passie, T. et al. 2012. Mitigation of post-traumatic stress symptoms by CANNABlS resin: A review of the clinical and neurobiological evidence. Drug Testing and Analysis. 4(7-8):649-59.

Paszcuk, A. et al. 2011. Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases. PLoS One. 6(9):e24034.

Pazos, M. et al. 2012. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 63(5):776-83.

Piñeiro, R. et al. 2011. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene. 30(2):142-52.

Pini, A. et al. 2012. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke.Current Drug Targets. 13(7):984-93.

Potenzieri, C. et al. 2008. Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation. Journal of Neurophysiology. 100(5):2794-806.

Pourkhalili, N. et al. 2013. Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells. Toxicology Mechanisms and Methods. 23(2):120-6.

Pryce, G. et al. 2003. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain. 126(10):2191-202.

Pucci, M. et al. 2013. Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids. British Journal of Pharmacology. doi: 10.1111/bph.12309. [Epub ahead of print]

Radwan, M. et al. 2009. Biologically active cannabinoids from high-potency CANNABlS sativa. Journal of Natural Products. 72(5):906-11.

Rajesh, M. et al. 2007. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. American Journal of Physiology. Heart and Circulatory Physiology. 293(1):H610–9.

Rajesh, M. et al. 2010. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. Journal of the American College of Cardiology. 56(25):2115-25.

Ramer, R. et al. 2010. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochemical Pharmacology. 79(7):955-66.

Ramírez, B. et al. 2005. Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. The Journal of Neuroscience. 25(8):1904-13.

Richardson, J., Kilo, S., and K. Hargreaves. 1998. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain. 75(1):111-9.

Robinson, R. et al. 2013. Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction. Journal of Neuroimmune Pharmacology. [Epub ahead of print]

Rogeberg, O. 2013. Correlations between CANNABlS use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proc. Natl. Acad. Sci. USA.110(11):4251-4.

Rosenfeld, I. (Author) Sanchez-Ramos, J., and M. Earleywine (Introduction). 2010. My Medicine. Open Archive Press. 286 pp. ISBN:0963638092.

Ruiz, L., Miguel, A., and I. Díaz-Laviada. 1999. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Letters. 458(3):400-4.

Russo, E. 2008. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of CANNABlS in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters. 29(2):192-200.

Russo, E. 2011. Taming THC: potential CANNABlS synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology. 163(7):1344-66.

Russo, E., and G. Guy. 2006. A tale of two cannabinoids; the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses. 66(2):234-46.

Schlosburg, J., O’Neal, S., Conrad, D., and A. Lichtman. 2011 CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. Psychopharmacology (Berl). 216(3):323-31.

Sagredo, O. et al. 2012. Cannabinoids: novel medicines for the treatment of Huntington’s disease. Recent Patents on CNS Drug Discovery. 7(1):41-8.

Sarfaraz, S. et al. 2005. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Research. 65(5):1635-41.

Sarfaraz, S. et al. 2008. Cannabinoids for cancer treatment: progress and promise. Cancer Research. 68(2):339-42.

Shrivastava, A. et al. 2011. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Molecular Cancer Therapeutics. 10(7):1161-72.

Schier, A. et al. 2012. Cannabidiol, a CANNABlS sativa constituent, as an anxiolytic drug. Brazilian Journal of Psychiatry. 34(Suppl.1):S104-10.

Schreiner, A., and M. Dunn. 2012. Residual effects of CANNABlS use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology. 20(5):420-9.

Solas, M., Francis, P., Franco, R., and M. Ramirez. 2013. CB2 receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients. Neurobiology of Aging. 34(3):805-8.

Storr, M. et al. 2009. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflammatory Bowel Diseases. 15(11):1678-85.

Tashkin, D. et al. 2009. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? Canadian Medical Association Journal. 180(8):797-8.

US Federal Government. US Patent #6630507. Cannabinoids as antioxidants and neuroprotectants. Filed: 2001. Issued: 2003.

Vara, D. et al. 2011. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death and Differentiation. 18(7):1099-111.

Vera, G. et al. 2012. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. Pharmacology, Biochemistry, and Behavior. 102(2):335-43.

Vuolo, M. 2013. National-level drug policy and young people’s illicit drug use: A multilevel analysis of the European Union. Drug and Alcohol Dependence. 131(1-2):149-56.

Ware, M. et al. 2010. Smoked CANNABlS for chronic neuropathic pain: a randomized controlled trial. Canadian Medical Association Journal. 182(14):E694-701.

Wargent, E. et al. 2013. The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutrition and Diabetes.3:e68.

Weiss, L. et al. 2006. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 39(2):143–151.

Whyte, D. et al. 2010. Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology. 85(6):328-35.

Wilkinson, J., and E. Williamson. 2007. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. Journal of Dermatological Sciences. 45(2):87-92.

Wright, K. et al. 2005. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology. 129(2):437-53.

Wu, J. et al. 2013. Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. Neurobiology of Aging. 34(3):791-804.

Xiong, W. et al. 2012. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. The Journal of Experimental Medicine. 209(6):1121-34.

Zani, A. et al. 2007. Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. British Journal of Pharmacology. 152(8):1301-11.

Zajicek J. et al. 2012. MUltiple Sclerosis and Extract of CANNABlS: results of the MUSEC trial. Journal of Neurology, Neurosurgery, and Psychiatry. 83(11):1125-32.

Zhu, H. et al. 2006. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. The Journal of Pharmacology and Experimental Therapeutics. 317(2):850-7.

Zuardi, A. et al. 2006. Cannabidiol, a CANNABlS sativa constituent, as an antipsychotic drug. Brazilian Journal of Medical and Biological Research. 39: 421-429.

Zuardi, A. et al. 2009. Cannabidiol for the treatment of psychosis in Parkinson’s disease. Journal of Psychopharmacology. 23(8):979-83.

By: Next

Next — Thu, 24 Oct 2013 20:26:23 +0000

He should be addressing what’s most pressing at this time and it’s surely not decriminalizing marijuana, read in context.

By: whataboutus

whataboutus — Thu, 24 Oct 2013 20:25:14 +0000

the govt has been wrong about marijuana for many years, and have done wicked to many Bermudian families, they need to surrender and legalize cultivation of marijuana for Bermudians. we righteously feel the govt hates us,so heal the nation. we don’t want compensation for years of cultural oppression, we want the govt to surrender on weed, and soon.

By: Mile High Club

Mile High Club — Thu, 24 Oct 2013 20:13:46 +0000

I agree. Decriminalize an amount up to what a user would carry, put punish the dealer and importer.

By: Um Um Like

Um Um Like — Thu, 24 Oct 2013 20:08:28 +0000

Legalize it and regulate it like alcohol (age requirements, etc). Build an industry around it. Generate tax revenue and create employment through the farms, retailers, cafes, etc… Market it as a tourist destination.

Many Americans can legally smoke a joint in their own country. Don’t you think they’d like to smoke a joint on one of our pink sand beaches?

High Bermuda!

By: Double Standards

Double Standards — Thu, 24 Oct 2013 19:56:47 +0000

So why didn’t they address them in the near decade and a half they were in power?

By: Tommy Chong

Tommy Chong — Thu, 24 Oct 2013 19:43:30 +0000

The majority of the security issues in Bermuda revolve around our drug laws causing illegal drugs to be the most lucrative uncontrolled trade on island that people will steal & kill for makes this a major security issue. Since Minister Dunkley is the security minister discussing better drug laws that will remove the power of the black market is by far the most important discussion towards a safer bermuda. Implementing intelligent fact based drug laws to replace the antiquated ones we have will solve our criminal problems way before any prayer group or neighbourhood watch will.